Faes Farma revenue and financials

FAE · BME · EUR

Compare Faes Farma
€4.83Change from previous close: −1.13%Absolute change: −€0.06

Close · November 20, 2026

In the fiscal year ended December 2025, Faes Farma reported revenue of €626.99M (+22.93% year over year). Net income was €79.63M, a net margin of 12.7%.

Annual revenue · 2025: €626.99M
  1. €236.86M2016
  2. €282.16M2017
  3. €339.92M2018
  4. €383.19M2019
  5. €411.49M2020
  6. €428.64M2021
  7. €461.72M2022
  8. €473.09M2023
  9. €510.04M2024
  10. €626.99M2025

Fiscal year ending in December. Sources and method on the page How we analyse stocks.

At a glance

Revenue growth
+22.93%
2025 vs 2024
Net income growth
−28.49%
2025 vs 2024
Net margin
12.7%
2024: 21.8%

How Faes Farma is changing

Calculated from the annual statements; each fiscal year is labelled with the year it ends.

Financial data

Amounts in millions of EUR; per-share values in EUR; shares in millions.

Income statement · Annual
Item2025202420232022202120202019201820172016
Total revenue627510473462429411383340282237
Cost of revenue22717416116315114613512499.580.0
Gross profit400336312299278265249216183157
Selling, general and administrative17013312211686.810510494.277.065.7
Research and development4.95.85.23.7——————
Operating income88.810910310297.192.378.862.049.147.8
EBIT88.810910310297.192.378.862.049.147.8
EBITDA11212511911811110489.271.957.253.3
Interest expense4.60.40.40.30.20.30.10.30.20.0
Pre-tax income85.410810310193.084.974.261.749.546.1
Income tax5.8-3.511.212.010.511.510.19.98.09.5
Net income79.611191.989.582.472.564.051.641.436.6
Net income to common shareholders79.611191.989.582.472.564.051.641.436.6
Basic EPS0.260.360.300.290.280.260.230.190.160.15
Diluted EPS0.250.360.300.290.270.250.230.190.160.15
Average shares (basic)311311310306291280273266258252
Average shares (diluted)313312311306305292273266258252
Dividend per share0.130.180.160.160.210.200.170.140.020.02

Companies in the group: same industry, similar size